Here's a scene every sales leader who has bought AI software will recognise. A vendor walks you through a polished platform, then names the number: a six-figure annual licence, a year's commitment, a deck full of the word "transformation." The product looks capable. The team in the room is keen. And still, something in you hesitates before signing. That hesitation isn't timidity. It's good judgement.

Because the odds are not on the platform's side. When most enterprise AI initiatives fail to deliver, asking a buyer to commit big before anything is proven loads almost all of the risk onto the one party who can least afford to be wrong. The fix isn't a better demo or a smoother contract. It's a different commercial model: sell the pilot, not the platform. Prove value on one real problem first, and let the expansion be earned rather than promised. That's what we mean by trust-based pricing - and it turns out to be better economics for the buyer and, less obviously, for the vendor too.

The numbers behind the buyer's hesitation

The scepticism is rational, and the data is blunt about why. An MIT study of enterprise AI in 2025 found that 95% of generative-AI pilots delivered no measurable impact on the P&L - the overwhelming majority produced no return at all.1 RAND, looking across the wider field, estimates that more than 80% of AI projects fail, roughly twice the failure rate of IT projects that don't involve AI.2 A buyer who pauses at a large up-front AI commitment isn't being difficult. They're pricing in a coin-flip that mostly comes up tails.

Buyers have responded by demanding proof instead of promises. In Forrester's 2025 buyer research, more than half of business buyers said they now treat a product trial as a decisive step before committing, and nearly one in five reported being less confident in their decisions because AI systems had produced inaccurate or misleading results.3 The market has learned to discount the pitch. The only thing it still trusts is evidence it generated itself.

Why the platform sale is structurally misaligned

A platform sale front-loads the revenue and back-loads the value. The vendor gets paid before the outcome exists; the buyer pays before they know it works. That's not a pricing detail - it's a misalignment of risk, and experienced buyers feel it in their gut even when they can't name it. The bigger the "transformation" framing, the worse it gets, because now the buyer is being asked to bet the organisation on a tool before a single workflow has been proven on their own data.

It also quietly insults the buyer's intelligence. They know the failure rates. Asking them to ignore those odds and trust a slide is, in effect, asking them to be the exception on faith. The sellers who win in this environment do the opposite: they put their own skin on the same side of the table as the buyer's.

What trust-based pricing actually is

Trust-based pricing is simple to state and harder to hold to: price the first engagement as a scoped pilot that solves one specific, measurable problem - not as a platform licence. The buyer pays for a contained outcome, watches it work (or not) on their own data and inside their own process, and only then decides whether to expand. Expansion is earned by results, not locked in by contract.

This is co-creation applied to the commercials. As we wrote in the case for co-creating instead of pitching, a customer who co-invests in a contained piece of work takes psychological ownership of it - and a pilot is exactly that kind of mutual, bounded investment. Both sides put something real in. Both sides find out quickly whether it works.

A platform sale asks the customer to believe. A pilot asks them to verify. When most AI projects don't deliver, verification is the only honest offer left.

Why this is better economics for the vendor, too

The objection writes itself: a pilot is a smaller first deal, so isn't this just leaving money on the table? In practice, no - because a smaller, lower-risk decision closes more often and closes faster. A scoped pilot rarely needs the full committee, the procurement gauntlet, or the board sign-off that a six-figure platform commitment triggers, so the cycle compresses. And the expansion that follows a proven result is grounded in evidence the customer trusts, which makes it far easier to win than the original platform sale would have been. Land-and-expand beats land-and-pray.

There's a reputational compounding effect, too. Because a pilot surfaces the truth cheaply, the deals that shouldn't proceed end before they damage anyone - and the ones that do proceed are built on a result the customer can point to internally. Over time, a vendor that consistently proves value before asking for scale becomes the low-risk choice in a category everyone else is overselling. In a market where 95% of pilots disappoint, being the name associated with the 5% that work is the most valuable position there is.

How to structure a pilot that earns the expansion

A pilot only does its job if it's designed to prove something. Loose pilots that drift into unpaid consulting are as damaging as platform oversell. The discipline:

  • Scope to one measurable problem. Not "AI transformation" - one workflow, one bottleneck, one number that should move. A cybersecurity vendor piloting an agent that drafts first-pass responses to security questionnaires is testing something falsifiable. A vendor piloting "an AI platform" is testing nothing.
  • Agree the success metric up front, with the customer. Decide together what "it worked" looks like before you start, so the expansion decision is evidence, not opinion.
  • Run it on real data and real process. A demo sandbox proves the vendor's best case; the customer's own data proves the only case that matters.
  • Make the expansion path explicit but uncommitted. The customer should know exactly what scaling looks like - and be under no obligation to take it until the pilot earns it.

This is how we build 4steps2win AI Sales Agents: one agent, one problem, delivered on a trust-based basis, so the customer sees a result before they ever face a bigger decision. The methodology and the pricing model are the same idea pointed at different parts of the deal - reduce the buyer's risk, and let proof do the persuading.

The honest offer wins

If you're evaluating AI for your sales organisation, the most useful question isn't "which platform?" It's "what's the one problem we'd pilot first, and how would we know it worked?" Any vendor worth buying from can answer that without a six-figure commitment attached. The ones who can't are asking you to be the exception on faith - and the data is fairly clear about how that usually ends.

Selling pilots instead of platforms isn't a discount or a hedge. It's the recognition that, in a market this sceptical and this prone to disappointment, the seller who carries some of the risk is the only one the buyer can afford to trust. Proof is the product now. Price it that way.

References

  1. Fortune. (2025). MIT report: 95% of generative AI pilots at companies are failing (reporting MIT Project NANDA, The GenAI Divide: State of AI in Business 2025). Fortune. https://fortune.com/2025/08/18/mit-report-95-percent-generative-ai-pilots-at-companies-failing-cfo/
  2. RAND Corporation. (2024). The Root Causes of Failure for Artificial Intelligence Projects and How They Can Succeed. RAND Corporation. https://www.rand.org/pubs/research_reports/RRA2680-1.html
  3. Forrester, via Digital Commerce 360. (2025). Forrester: B2B buyers now demand proof, not promises, about AI (Forrester Buyers' Journey Survey, 2025). Digital Commerce 360. https://www.digitalcommerce360.com/2025/10/28/forrester-b2b-buyers-demand-proof-not-promises/